French National AIDS Council issues opinion on the potential benefits of the concept of HIV/AIDS Pre-Exposure Prophylaxis (PrEP)

The CNS wishes to publish this opinion today, at a time when a committee of experts recommended the FDA to approve a supplemental New Drug Application for an antiretroviral treatment to be used for PrEP.